Literature DB >> 29503979

Whole exome analyses to examine the impact of rare variants on left ventricular traits in African American participants from the HyperGEN and GENOA studies.

Anh N Do1, Wei Zhao2, Vinodh Srinivasasainagendra3, Stella Aslibekyan1, Hemant K Tiwari3, Nita Limdi4, Sanjiv J Shah5, Degui Zhi3, Uli Broeckel6, C Charles Gu7, D C Rao7, Karen Schwander7, Jennifer A Smith2, Sharon L R Kardia2, Donna K Arnett8, Marguerite R Irvin1.   

Abstract

Left ventricular (LV) hypertrophy, highest in prevalence among African Americans, is an established risk factor heart failure. Several genome wide association studies have identified common variants associated with LV-related quantitative-traits in African Americans. To date, however, the effect of rare variants on these traits has not been extensively studied, especially in minority groups. We therefore investigated the association between rare variants and LV traits among 1,934 African Americans using exome chip data from the Hypertension Genetic Epidemiology Network (HyperGEN) study, with replication in 1,090 African American from the Genetic Epidemiology Network of Arteriopathy (GENOA) study. We used single-variant analyses and gene-based tests to investigate the association between 86,927 variants and six structural and functional LV traits including LV mass, LV internal dimension-diastole, relative wall thickness, left atrial dimension (LAD), fractional shortening (FS), and the ratio of LV early-to-late transmitral velocity (E/A ratio). Only rare variants (MAF <1% and <5%) were considered in gene-based analyses. In gene-based analyses, we found a statistically significant association between potassium voltage-gated channel subfamily H member 4 (KCNH4) and E/A ratio (P=8.7*10-8 using a burden test). Endonuclease G (ENDOG) was associated with LAD using the Madsen Browning weighted burden (MB) test (P=1.4*10-7). Neither gene result was replicated in GENOA, but the direction of effect of single variants in common was comparable. G protein-coupled receptor 55 (GPR55) was marginally associated with LAD in HyperGEN (P=3.2*10-5 using the MB test) and E/A ratio in GENOA, but with opposing directions of association for variants in common (P=0.03 for the MB test). No single variant was statistically significantly associated with any trait after correcting for multiple testing. The findings in this study highlight the potential cumulative contributions of rare variants to LV traits which, if validated, could improve our understanding of heart failure in African Americans.

Entities:  

Keywords:  African Americans; echocardiography; epidemiology; genetics; left ventricular traits; rare variants

Year:  2017        PMID: 29503979      PMCID: PMC5831560          DOI: 10.23937/2474-3690/1510025

Source DB:  PubMed          Journal:  J Hypertens Manag        ISSN: 2474-3690


  46 in total

1.  Multi-center genetic study of hypertension: The Family Blood Pressure Program (FBPP).

Authors: 
Journal:  Hypertension       Date:  2002-01       Impact factor: 10.190

2.  Pooled association tests for rare variants in exon-resequencing studies.

Authors:  Alkes L Price; Gregory V Kryukov; Paul I W de Bakker; Shaun M Purcell; Jeff Staples; Lee-Jen Wei; Shamil R Sunyaev
Journal:  Am J Hum Genet       Date:  2010-05-13       Impact factor: 11.025

3.  Genetic variation in NCAM1 contributes to left ventricular wall thickness in hypertensive families.

Authors:  Donna K Arnett; Kristin J Meyers; Richard B Devereux; Hemant K Tiwari; Charles C Gu; Laura K Vaughan; Rodney T Perry; Amit Patki; Steven A Claas; Yan V Sun; Ulrich Broeckel; Sharon L Kardia
Journal:  Circ Res       Date:  2011-01-06       Impact factor: 17.367

Review 4.  Systolic and diastolic left ventricular dysfunction: from risk factors to overt heart failure.

Authors:  Tatiana Kuznetsova; Lieven Herbots; Yu Jin; Katarzyna Stolarz-Skrzypek; Jan A Staessen
Journal:  Expert Rev Cardiovasc Ther       Date:  2010-02

5.  The role of rare variants in systolic blood pressure: analysis of ExomeChip data in HyperGEN African Americans.

Authors:  Yun Ju Sung; Jacob Basson; Nuo Cheng; Khanh-Dung H Nguyen; Priyanka Nandakumar; Steven C Hunt; Donna K Arnett; Victor G Dávila-Román; Dabeeru C Rao; Aravinda Chakravarti
Journal:  Hum Hered       Date:  2015       Impact factor: 0.444

6.  Transplantation of mesenchymal stem cells carrying the human receptor activity-modifying protein 1 gene improves cardiac function and inhibits neointimal proliferation in the carotid angioplasty and myocardial infarction rabbit model.

Authors:  Bei Shi; Xianping Long; Ranzun Zhao; Zhijiang Liu; Dongmei Wang; Guanxue Xu
Journal:  Exp Biol Med (Maywood)       Date:  2014-01-29

7.  Receptor activity-modifying protein 1 increases baroreflex sensitivity and attenuates Angiotensin-induced hypertension.

Authors:  Rasna Sabharwal; Zhongming Zhang; Yongjun Lu; Francois M Abboud; Andrew F Russo; Mark W Chapleau
Journal:  Hypertension       Date:  2010-01-25       Impact factor: 10.190

8.  Population structure and eigenanalysis.

Authors:  Nick Patterson; Alkes L Price; David Reich
Journal:  PLoS Genet       Date:  2006-12       Impact factor: 5.917

9.  RAREMETAL: fast and powerful meta-analysis for rare variants.

Authors:  Shuang Feng; Dajiang Liu; Xiaowei Zhan; Mary Kate Wing; Gonçalo R Abecasis
Journal:  Bioinformatics       Date:  2014-06-03       Impact factor: 6.937

10.  KIAA1199 interacts with glycogen phosphorylase kinase β-subunit (PHKB) to promote glycogen breakdown and cancer cell survival.

Authors:  Masato Terashima; Yoshihiko Fujita; Yosuke Togashi; Kazuko Sakai; Marco A De Velasco; Shuta Tomida; Kazuto Nishio
Journal:  Oncotarget       Date:  2014-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.